NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
12 févr. 2025 08h00 HE
|
NeuroOne Medical Technologies Corporation
Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from Zimmer Biomet EDEN PRAIRIE, Minn., Feb. 12, 2025 ...
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
05 févr. 2025 11h00 HE
|
NeuroOne Medical Technologies Corporation
EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Regains Compliance with Nasdaq Listing Requirements
04 févr. 2025 10h56 HE
|
NeuroOne Medical Technologies Corporation
EDEN PRAIRIE, Minn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million
10 janv. 2025 08h30 HE
|
NeuroOne Medical Technologies Corporation
First Quarter Fiscal 2025 Revenue Includes a One-Time Upfront Payment of $3.0 Million in Collaboration Revenue from Zimmer Biomet and $3.2M in Product Revenue Management to Host Virtual Investor...
NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024
06 janv. 2025 08h30 HE
|
NeuroOne Medical Technologies Corp
Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation...
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
03 janv. 2025 08h30 HE
|
NeuroOne Medical Technologies Corp
Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation...
NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time
04 déc. 2024 08h30 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Dec. 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System
31 oct. 2024 16h01 HE
|
NeuroOne Medical Technologies Corp
License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS MarketsAgreement expected to boost NeuroOne sales revenue and profitability EDEN PRAIRIE, Minn., Oct. 31,...
NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference
24 sept. 2024 09h30 HE
|
NeuroOne Medical Technologies Corp
Minimally invasive technology would allow for percutaneous placement of a paddle electrode Renowned pain specialist Dr. Sean Li to present on this innovative tool for lower back pain EDEN PRAIRIE,...
NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland
10 sept. 2024 09h00 HE
|
NeuroOne Medical Technologies Corp
Forty-four ablations performed successfully in one patient Patient currently reportedly seizure free with improvements in mood and memory EDEN PRAIRIE, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE)...